Cognetivity Neurosciences Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Cognetivity Neurosciences Ltd is a Canadian healthcare technology company focused on developing diagnostic tools for early detection of cognitive decline. The company’s platform uses artificial intelligence and digital testing methods to assess brain health in clinical and non-clinical environments. Its technology is targeted for applications in neurology, psychiatry, and general health screening. Cognetivity Neurosciences Ltd is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
CGNSF
Country
🇨🇦 Canada